Digital Insomnia Therapeutics Market Report 2026

Digital Insomnia Therapeutics Market Overview

• Digital Insomnia Therapeutics market size has reached to $3.48 billion in 2025 • Expected to grow to $4.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Rising Adoption Of Digital Health Driving Growth In The Digital Insomnia Therapeutics Market • Market Trend: A Breakthrough In Digital Insomnia Therapeutics For Chronic Insomnia Management • North America was the largest region in 2025.

What Is Covered Under Digital Insomnia Therapeutics Market?

Digital insomnia therapeutics refer to technology-driven solutions designed to treat or manage insomnia by improving sleep quality and addressing its underlying causes. These therapies leverage tools such as mobile apps, wearable devices, and online platforms to deliver evidence-based interventions. A common approach is cognitive behavioral therapy for insomnia which targets the negative thoughts and habits affecting sleep. The main types of digital insomnia therapeutics are sleep tracking apps, relaxation and meditation apps, cognitive-behavioral therapy for insomnia (CBT-I), wearable devices, and other types. Sleep tracking apps monitor and analyze sleep patterns, providing actionable insights and recommendations to improve sleep quality and address potential issues. It is distributed through various channels, such as hospital pharmacies, retail pharmacies, and other distribution channels, and it is used in a variety of applications, including medical and household.

What Is The Digital Insomnia Therapeutics Market Growth Forecast?

The digital insomnia therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.7 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to clinical validation of digital therapeutics, wearable data integration, demand for drug-free treatments, ai-driven sleep analytics, telehealth expansion. Major trends in the forecast period include rising adoption of digital cbt-i programs, increasing use of sleep tracking applications, growth of non-pharmacological sleep therapies, expansion of app-based insomnia management, integration of wearables for sleep monitoring.

Global Digital Insomnia Therapeutics Market Segmentation

1) By Type: Sleep Tracking Apps, Relaxation And Meditation Apps, Cognitive-Behavioral Therapy For Insomnia (CBT-I), Wearable Devices, Other Types 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels 3) By Applications: Medical, Household Subsegments: 1) By Sleep Tracking Apps: Basic Sleep Monitoring Apps, Advanced Sleep Monitoring Apps, Smart Alarm Apps 2) By Relaxation And Meditation Apps: Guided Meditation Apps, Breathing Exercise Apps, Sleep-Inducing Music Apps 3) By Cognitive-Behavioral Therapy For Insomnia (CBT-I): Digital CBT-I Programs, CBT-I Mobile Apps, Online CBT-I Therapy Platforms 4) By Wearable Devices: Sleep-Tracking Wearables, Smartwatches With Sleep Tracking, Wearable Devices With Biofeedback For Insomnia 5) By Other Types: Virtual Reality (VR) Therapy For Insomnia, Biofeedback Devices, Transcranial Magnetic Stimulation (TMS) Devices For Sleep

What Is The Driver Of The Digital Insomnia Therapeutics Market?

The rising adoption of digital health is expected to propel the digital insomnia therapeutics market going forward. Digital health refers to the use of digital technologies, tools, and platforms to enhance healthcare delivery, improve patient outcomes, and empower individuals to manage their health effectively. The adoption of digital health is rising due to factors such as increasing demand for accessible and cost-effective healthcare solutions, the growing prevalence of chronic diseases, heightened awareness of preventive care, and the expansion of telehealth services. Digital insomnia therapeutics contribute to digital health by providing technology-driven solutions, such as mobile apps and wearable devices, to monitor, diagnose, and manage sleep disorders, promoting better overall health outcomes and integration with broader healthcare systems. For instance, in July 2024, according to the European Commission, a Belgium-based organization, the Digital Decade e Health Indicator Study found that in EU average access to electronic health records (EHR) via online portals rose to 79%, up from 72% in 2022. Therefore, the rise in the adoption of digital health is driving the growth of the digital insomnia therapeutics industry.

Key Players In The Global Digital Insomnia Therapeutics Market

Major companies operating in the digital insomnia therapeutics market are Pear Therapeutics Inc., Calm.com Inc., Headspace Inc., Big Health Inc., Click Therapeutics Inc., Silvercloud Health Limited, OPTT Inc., Bodymatter Inc., SleepCogni Limited, Stellar Sleep, SleepScore Labs, Sliiip, SUSMED Inc., HelloBetter, AIMMED, Sleepstation (Born Digital Health), NOCTEM Health, Somryst, BetterNight, Minddistrict, Sleep Reset, SleepSpace, Black Dog Institute (Sleep Ninja), Insomnia‑Coach, CBT‑i Coach, ZenSleep, DrLullaby, Night Owl Sleep Coach

Global Digital Insomnia Therapeutics Market Trends and Insights

Major companies operating in the digital insomnia therapeutics market are focusing on developing advanced solutions such as software-based mobile apps to provide personalized, accessible, and cost-effective treatment options for managing insomnia. A software-based mobile app refers to a digital application designed for smartphones or tablets that helps manage insomnia through features like sleep tracking, relaxation exercises, cognitive behavioral therapy, and personalized sleep recommendations. For instance, in August 2024, Big Health Inc., a US-based mental health services company, announced the United States Food and Drug Administration approval for SleepioRx for the treatment of adults' chronic insomnia as a supplement to standard care. SleepioRx is intended for the treatment of chronic insomnia and insomnia disorder as an adjunct to usual care in adults over 18. It delivers evidence-based techniques that target the cognitive and behavioral factors that maintain chronic insomnia and sleep problems.

What Are Latest Mergers And Acquisitions In The Digital Insomnia Therapeutics Market?

In June 2023, Nox Health Inc., a US-based provider of sleep diagnostics and value-based sleep care management, acquired Somryst for an undisclosed amount. With this acquisition, Nox Health gains access to Somryst’s FDA-cleared digital insomnia therapeutic program and evidence-based CBT-I technology, thereby enhancing its digital sleep-care capabilities while improving its operational scale and reach across patient populations. Somryst is a US-based digital therapeutics solution for chronic insomnia known for being the first FDA-cleared prescription digital therapeutic for insomnia.

Regional Outlook

North America was the largest region in the digital insomnia therapeutics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Digital Insomnia Therapeutics Market?

The digital insomnia therapeutics market includes revenues earned by entities by providing services such as cognitive behavioral therapy for insomnia (CBT-I), sleep monitoring, relaxation techniques, and telehealth consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The digital insomnia therapeutics market consists of sales of virtual cognitive behavioral therapy, audio & video-based sleep aids, light and sound therapy devices, and sleep monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Digital Insomnia Therapeutics Market Report 2026?

The digital insomnia therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the digital insomnia therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.